Haorui Industrial Dev.Co.,Ltd

You are here: HomeProductsN-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2- methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide

Contact us

  • Company Name: Haorui Industrial Dev.Co.,Ltd
  • Street: Guangdong Province
  • City: guangdong province
  • Country/region: China
  • Contact Person: Ms.Aillen LIU
  • Department: Marketing
  • Tel: 86-755-82960263
  • Fax: 86-755-82960262
  • Email:

N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2- methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide

  • Product NameN-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2- methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
    CAS No.863127-77-9
    Purity
    Min Quantity
    Price~
  • View Contact Detail
  • CAS No:863127-77-9 N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-<br />methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
    Molecular Structure

    Detailed Description

    Dasatinib monohydrate: USFDA Approved, USDMF available,Stability Studies In Zone IVB.
    Haorui, established in 1997, is a manufacturer and supplier of APIs, intermediates, veterinary and food additives.
    Our USFDA approved products Flumazenil, Granisetron HCl, Granisetron Base, Docetaxel Anhydrous, Irinotecan HCl, Dasatinib Monohydrate, Oxaliplatin and Temozolomide have been recognized by our customers globally.
    Our USFDA approved factory, Hubei Haosun Pharma. Co., Ltd., is subject to cGMP. It is periodically inspected by China FDA, US FDA, EDQM, UK MHRA, Mexico Authority, etc. In 2018, we successfully passed the USFDA inspection with zero observation.
    Any inquiry, please contact lena@haorui.com or info@haorui.com.